{{Drugbox
| IUPAC_name = 1-naphthalenyl(1-pentyl-1H-indazol-3-yl)-methanone
| image = THJ-018_structure.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = 
| pregnancy_US = 
| pregnancy_category =  
| legal_AU = 
| legal_CA = Schedule II
| legal_UK = 
| legal_US = 
| legal_DE = Anlage II
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number =  1364933-55-0
| ATC_prefix =  
| ATC_suffix =  
| PubChem =  
| ChemSpiderID      = 29341702
| smiles            = O=C(C1=NN(CCCCC)C2=C1C=CC=C2)C3=C4C(C=CC=C4)=CC=C3
| StdInChI          = 1S/C23H22N2O/c1-2-3-8-16-25-21-15-7-6-13-20(21)22(24-25)23(26)19-14-9-11-17-10-4-5-12-18(17)19/h4-7,9-15H,2-3,8,16H2,1H3
| StdInChIKey       = VAKGBPSFDNTMDJ-UHFFFAOYSA-N

<!--Chemical data-->
| C=23 | H=22 | N=2 | O=1 
| molecular_weight = 342.4 g/mol
}}

'''THJ-018''' is a [[synthetic cannabinoid]] that is the [[indazole]] analogue of [[JWH-018]] and has been sold online as a [[designer drug]].<ref>{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/11962 | title=THJ-018 | publisher=Cayman Chemical | accessdate=9 July 2015}}</ref><ref>{{cite journal | url=http://www.clinchem.org/content/early/2015/08/31/clinchem.2015.243535.abstract | title=High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes |author1=Xingxing Diao |author2=Ariane Wohlfarth |author3=Shaokun Pang |author4=Karl B. Scheidweiler |author5=Marilyn A. Huestis | journal=Clinical Chemistry | date=October 2015 | doi=10.1373/clinchem.2015.243535 | pmid=26430074}}</ref>

==Pharmacology==
THJ-018 acts as a [[full agonist]] with a [[Affinity (pharmacology)#Protein-ligand binding|binding affinity]] of 5.84nM at [[Cannabinoid receptor type 1|CB<sub>1</sub>]] and 4.57nM at [[Cannabinoid receptor type 2|CB<sub>2</sub>]] [[cannabinoid]] receptors.<ref>{{cite journal|first1=Cornelius|last1=Hess|first2=ClaraT.|last2=Schoeder|first3=Thanigaimalai|last3=Pillaiyar|first4=Burkhard|last4=Madea|title=Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice|journal=Forensic Toxicology|date=1 July 2016|issn=1860-8965|pages=329–343|volume=34|issue=2|doi=10.1007/s11419-016-0320-2|first5=ChristaE.|last5=Müller|pmid=27429655|pmc=4929166}}</ref>

==Legality==
THJ-018 is an [[Drugs controlled by the German Betäubungsmittelgesetz|Anlage II]] controlled drug in Germany.<ref>{{cite web | url=http://www.gesetze-im-internet.de/btmg_1981/anlage_ii.html | title=Gesetz über den Verkehr mit Betäubungsmitteln (Betäubungsmittelgesetz - BtMG) Anlage II (zu § 1 Abs. 1) (verkehrsfähige, aber nicht verschreibungsfähige Betäubungsmittel) | language=German | accessdate=9 July 2015}}</ref> It is also banned in Sweden.<ref>{{cite web | url=http://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2014/november/cannabinoider-foreslas-bli-klassade-som-halsofarlig-vara/ | title=Cannabinoider föreslås bli klassade som hälsofarlig vara | publisher=Folkhälsomyndigheten | language=Swedish | accessdate=9 July 2015}}</ref>

==See also==
* [[THJ-2201]]
* [[AM-2201]]

==References==
{{Reflist}}

{{Cannabinoids}}
{{Cannabinoidergics}}

[[Category:Cannabinoids]]
[[Category:Designer drugs]]
[[Category:Naphthoylindazoles]]
[[Category:Naphthalenes]]


{{cannabinoid-stub}}